Med Lasers 2022; 11(4): 195-200
Efficacy of low-level light therapy for tinnitus: a narrative review
Ji Eun Choi1,2
1Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital, Cheonan, Republic of Korea
2Department of Medical Science, College of Medicine, Dankook University, Cheonan, Republic of Korea
Correspondence to: Ji Eun Choi
Received: August 10, 2022; Accepted: September 2, 2022; Published online: December 30, 2022.
© Korean Society for Laser Medicine and Surgery. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Low-level light therapy (LLLT) has been investigated to reduce tinnitus severity, but it remains controversial whether LLLT can effectively alleviate tinnitus. Here, I reviewed the efficacy of LLLT on patients with complaints of tinnitus. The PubMed database was searched to find relevant articles. Ten randomized control trials (RCTs) involving 588 patients were included. Of these ten RCTs, four studies reported different levels of improvement in tinnitus symptoms; the other six found no significant effect. The study shows that the therapeutic effects of LLLT on tinnitus remain controversial and that reports on the topic are inconsistent.
Keywords: Lower level laser; Lower level light; Tinnitus; Clinical study

Tinnitus is a common disorder characterized by the phantom auditory perception of sounds without external or internal auditory stimuli. Reported prevalence of tinnitus ranges from 19.7% to 25.3% in nation-wide studies [1,2]. For some subjects, tinnitus is disabling. It can result in sleep deprivation, loss of concentration, psychological distress, and depression [3,4]. Therefore, this symptom has forced clinicians to attempt to establish protocols for relieving tinnitus. There are various therapeutic modalities in the treatment of chronic tinnitus, including medications (antihistamines, sedatives, antiepileptics, antidepressants, antipsychotics, and vasodilators), psychotherapy, tinnitus retraining therapy, transcranial magnetic stimulation, and transcutaneous electrical stimulation. However, none of these symptomatic treatments has resulted in significant or lasting improvement of tinnitus.

Low-level light therapy (LLLT) was proposed as a therapeutic procedure for tinnitus over 20 years ago [5-7]. In contrast to high power lasers used to cut or destroy tissues, LLLT uses low-energy-lasers or light-emitting diodes to stimulate or inhibit cellular function [8]. Although the exact mechanism involved in the effect of LLLT on tinnitus is not clearly understood yet, it has been assumed to be a photochemical and photophysical stimulator of the mitochondria in hair cells [9,10]. LLLT acts by increasing blood microcirculation through sympathetic neural inhibition [11], increasing oxygen supply to hypoxic cell [12], prompting an increase in cell proliferation [13], enhancing adenosine triphosphate synthesis in mitochondria [14,15], and releasing various growth factors [16].

However, there are still some controversies concerning the effectiveness of LLLT in treating tinnitus as only some studies have shown positive results [9,17-21]. This discrepancy might be caused by inconsistencies in several technical parameters. First, as higher wavelength laser would deliver a larger amount of irradiance through greater penetration, different degrees of laser light transmission to the cochlea might have caused different therapeutic outcomes. Earlier studies evaluating LLLT with a wavelength of 650 nm have reported no significant reduction of symptoms in chronic tinnitus [6,7]. However, an infrared laser, especially at wavelengths around 800 nm [22], has a lower absorption of water, which enables a greater amount of energy to more deeply penetrate target tissues. Thus, it can transfer energy to hair cells and auditory nerves without being absorbed by the lymphatic fluid in the cochlea. Recent animal studies have suggested that a LLLT with a wavelength of 810-830 nm might promote hair cell survival following gentamicin damage in the cochlea and reduce salicylate-induced tinnitus [23]. Second, delivery route might also influence results of LLLT. LLLT delivered to the cochlea via the mastoid process is expected to be greatly absorbed by temporal bone. However, trans-tympanic delivery of LLLT shows more irradiation penetration since a less bony structures hinders irradiation [24]. Finally, different laser parameters (e.g., laser type, wavelength, output power), irradiation route (e.g., mastoid, external auditory meatus), and treatment schedules (e.g., frequency of treatments) might have caused different results [25]. In addition, inconsistencies of patient selection and measurement between studies further hinder authors and clinicians from making comparisons among studies. Considering these issues, the aim of the present study was to narratively review the current literature on LLLT to explore the true effect of LLLT.


A search was performed in PubMed database. It was restricted to the English language. Selected keywords were “low-level laser” OR “photobiomodulation” OR “phototherapy” AND “tinnitus”. The author also performed hand search of references of the selected studies to identify other possible relevant studies. Articles included should necessarily be presented with full access to the text. I verified those articles that presented titles and summaries that approached the subject of this research as well as methodology, results, and relevance for tis practical application.


Study characteristics

Ten studies with 588 patients have compared effects of LLLT with a placebo on patients with complaints of tinnitus. Characteristics of these studies are presented in Table 1. Seven studies used a low laser device with an intensity of 5 mW and a wavelength of 650 nm [5-7,19,26-28]. One study used the device with an intensity of 60 mW and a wavelength of 810 nm [29]. One study used the device with an intensity of 50 mW and a wavelength of 830 nm [30]. One study used the device with an intensity of 100 mW and a wavelength of 830 nm [21]. Nine studies applied light on the tympanic membrane through an auditory ear canal [5-7,19,21,26,27,29,30]. Only one study applied light to the ear via mastoid bone [28]. All but one study enrolled patients with chronic tinnitus lasting for at least three months [5-7,19,21,26,27,29,30]. One study did not report the duration of tinnitus [28]. Five studies included patients with cochlear tinnitus [7,21,27-29], whereas three studies included patients with idiopathic tinnitus [6,27,30]. The other two studies included patients with both tinnitus [5,19]. All studies used a sham laser as placebo intervention [5-7,19,21,26-30]. Five studies irradiated laser unilaterally [5-7,21,30], while other studies did not further report the laterality [19,26-29]. More detailed information regarding the sample size, laser modalities, and protocol of LLLT are presented in Table 1.

Table 1 . Characteristics of included studies

Study (yr)Sample sizeComorbidity; duration of tinnitus (mon)Treatment lateralityMethod of LLLTDelivery method
Choi et al. (2019) [21]38SNHL; >3Unilateral100 mW; 830 nm; 20 min/d for 10 sessions; 5 times/wk
TINI device (WONTECH, Republic of Korea)
Dehkordi et al. (2015) [6]66Idiopathic; 48 for treatment group and 34 for control groupUnilateral5 mW; 650 nm; 10 min/d for 20 sessions; 5 times/wk
Tinnimed® laser device (HT International, Germany)
Mirvakili et al. (2014) [26]120SNHL; >12Not reported5 mW; 650 nm; 20 min/d for 20 sessions; 3 times/wk
TINNImed laser device (Switzerland)
Ngao et al. (2014) [27]43Idiopathic; >6Not reported5 mW; 650 nm; 20 min/d for 70 sessions; 7 times/wk
MedicLaser® + Tinnitool® (DisMark GmbH, Switzerland)
Mollasadeghi et al. (2013) [28]82SNHL (NIHL); 22 (average)Not reported5 mW; 650 nm; 20 min/d for 20 sessions; every other day
TINNImed laser device (Switzerland)
Teggi et al. (2009) [7]54SNHL; 26 for both groupsUnilateral5 mW; 650 nm; 20 min/d for 90 sessions; once daily
New-developed TCL-system with four different diode lasers
Cuda and De Caria (2008) [19]46Mixed (84.8% SNHL; 15.2% idiopathic); >36Not reported5 mW; 650 nm; 20 min/d for 90 sessions; once daily
TinniTool EarLaser (DisMark GmbH)
Gungor et al. (2008) [5]45 (66a))Mixed (54% SNHL; 45% idiopathic); 96 (average)Unilateral5 mW; 650 nm; 15 min/d for 7 sessions; once daily
Tinnimed® laser device (HT International)
Nakashima et al. (2002) [29]45 (68a))SNHL; not reportedNot reported60 mW; 810 nm; 6 min/d for 4 sessions; once a week
SOFT LASERY JQ 310 (Minato Medical Science, Japan)
Mirz et al. (1999) [30]49Idiopathic; 70 for treatment group and 62 for control groupUnilateral50 mW; 830 nm; 15 min/time for 15 sessions; 5 consecutive days per a week
Uni-laser 310P, type 201.000, 3B

LLLT, low-level light therapy; SNHL, sensorineural hearing loss; NIHL, noise-induced hearing loss; TCL, transmeatal cochlear laser.

a)Used ears as the study subjects.

Outcomes and adverse events

Table 2 shows outcomes and adverse events. Tinnitus Handicap Inventory (THI) scores were measured after LLLT in seven studies [7,19,21,26-28,30]. Nine studies evaluated the severity of tinnitus according to rating scale scores [5-7,21,26-30]. One study evaluated a number of psychosocial questionnaires such as Beck Depression Inventory and State-Trait Anxiety Inventory [30]. Six studies revealed no statistically significant differences in outcomes between the LLLT group and the sham group [6,7,21,27,29,30]. However, four studies concluded that LLLT was effective in improving tinnitus [5,19,26,28]. All four studies showing positive results used the device at a wavelength of 650 nm. Of these studies, two enrolled patients with sensorineural hearing loss (SNHL) [26,28] and the other two enrolled patients with mixed tinnitus involving SNHL and idiopathic tinnitus [5,19]. Adverse events were reported qualitatively in three studies [5,21,29]. Only one patient developed a sudden onset hearing loss and one patient developed dizziness during the course of LLLT [29].

Table 2 . List of outcomes and adverse events

Study (yr)Evaluation methodEvaluation timingResultReported adverse event
Choi et al. (2019) [21]NRS of loudness, duration, and annoyance, THI, Psychoacoustical matches of tinnitus loudness, and MMLImmediately, 2 weeks after treatmentNo statistically significant differences between two groupsNo AEs observed
Dehkordi et al. (2015) [6]NRS of loudness, TSI, Psychoacoustical matches of tinnitus loudnessImmediatelyNo statistically significant differences between two groupsNot reported
Mirvakili et al. (2014) [26]VAS of severity, THIImmediately, 3 months after treatmentShort-term treatment of LLLT was effective, but its impact may be reduced over the timeNot reported
Ngao et al. (2014) [27]VAS of annoyance, sleep disruption, depression, concentration, loudness, and pitch, THIImmediatelyNot significantly superior to placebo effect in improving tinnitusNot reported
Mollasadeghi et al. (2013) [28]VAS of loudness, THI, Psychoacoustical matches of tinnitus loudnessImmediately, 3 months after treatmentShort-term treatment of LLLT was effective, but an effect that was weakened after 3 months follow-upNot reported
Teggi et al. (2009) [7]VAS of loudness, THI, Psychoacoustical matches of pitch, loudness, and MMLImmediatelyNo efficacy as a therapeutic measure for tinnitusNot reported
Cuda and De Caria (2008) [19]THIImmediatelyThe THI scores more significantly improved in the group receiving LLLTNot reported
Gungor et al. (2008) [5]VRS of loudness, duration, and annoyance2 weeks after treatmentThe loudness, duration, and degree of annoyance of tinnitus were improved in LLLT group. No significant improvement was observed in the placebo laser groupNo AEs observed
Nakashima et al. (2002) [29]VRS of loudness, duration, and annoyance1 week after treatmentNo significant difference was observed between two groupsSudden hearing loss and dizziness
Mirz et al. (1999) [30]VAS of loudness, annoyance, and attention involved, THI, TCSQ, BDI, STAIImmediatelyNo statistically significant differences between two groupsNot reported

NRS, numeric rating scale; THI, Tinnitus Handicap Inventory; MML, minimum masking levels; TSI, Tinnitus Severity Index; VAS, visual analogue scale; VRS, verbal rating scale; TCSQ, Tinnitus Coping Style Questionnaire; BDI, Beck Depression Inventory; STAI, State-Trait Anxiety Inventory; LLLT, low-level light therapy; AE, adverse effect.


Results of efficacy of LLLT for patients with tinnitus were inconsistent. A previously reported meta-analysis has concluded that the pooled effect estimate of five control-case studies does not show a significant difference in THI score after treatment [31]. They failed to demonstrate a significant difference in THI score between the LLLT group and the control group in the subgroup analysis [31].

Many studies have demonstrated a positive effect of LLLT on tinnitus [9,17-21,32]. However, when compared to controls, it is hard to say that LLLT has a favorable effect on tinnitus regardless of the measurement method or laser parameters. Evidence from many studies has suggested that most forms of subjective tinnitus result from a loss of inhibition secondary to cochlear damage in central auditory structures [33,34]. This loss of inhibition can disrupt the normal synchronized neural activity constrained by feed-forward inhibition to acoustic features of stimulus. Thus, neural networks in the central auditory pathway might have been aberrantly increased to compensate the under-activity of brain regions related to cochlear damage. Although therapeutic effects of LLLT on tinnitus are still under investigation, LLLT may compensate for sensory deprivation in the auditory system. Montazeri et al. (2017) [32] have demonstrated that LLLT can increase compound action potential amplitude without changing otoacoustic emissions. This result may support the fact that LLLT can alleviate tinnitus by reducing neural network activity rather than healing cochlear damage. Patients enrolled for case-control studies might not be effective or appropriate enough. Among included studies, the study of Mollasadeghi et al. (2013) [28] was the only study that enrolled patients with chronic tinnitus caused by noise-induced haring loss. A noise trauma can result in injury to hair cells in the inner ear and degeneration of the auditory nerve. As discussed earlier, patients who sustained injury from noise trauma to the cochlea might benefit the most from irradiation by compensating sensory deprivation in auditory system. Thus, further studies are required to support the effect of LLLT on tinnitus mainly caused by a specific inner ear disease or injury.


I evaluated the efficacy of LLLT in patients with tinnitus. Results still showed inconsistent effect of LLLT. Further large-scale studies are needed to evaluate the efficacy of this therapy on tinnitus mainly caused by abnormal neural networks in the central auditory pathway.




All work was done by JEC.


Ji Eun Choi is an editorial board member of the journal but was not involved in the review process of this manuscript. Otherwise, there is no conflict of interest to declare.





  1. Kim HJ, Lee HJ, An SY, Sim S, Park B, Kim SW, et al. Analysis of the prevalence and associated risk factors of tinnitus in adults. PLoS One 2015;10:e0127578.
    Pubmed KoreaMed CrossRef
  2. Park KH, Lee SH, Koo JW, Park HY, Lee KY, Choi YS, et al. Prevalence and associated factors of tinnitus: data from the Korean National Health and Nutrition Examination Survey 2009-2011. J Epidemiol 2014;24:417-26.
    Pubmed KoreaMed CrossRef
  3. Zarenoe R, Ledin T. A cohort study of patients with tinnitus and sensorineural hearing loss in a Swedish population. Auris Nasus Larynx 2013;40:41-5.
    Pubmed CrossRef
  4. Leaver AM, Renier L, Chevillet MA, Morgan S, Kim HJ, Rauschecker JP. Dysregulation of limbic and auditory networks in tinnitus. Neuron 2011;69:33-43.
    Pubmed KoreaMed CrossRef
  5. Gungor A, Dogru S, Cincik H, Erkul E, Poyrazoglu E. Effectiveness of transmeatal low power laser irradiation for chronic tinnitus. J Laryngol Otol 2008;122:447-51.
    Pubmed CrossRef
  6. Dehkordi MA, Einolghozati S, Ghasemi SM, Abolbashari S, Meshkat M, Behzad H. Effect of low-level laser therapy in the treatment of cochlear tinnitus: a double-blind, placebo-controlled study. Ear Nose Throat J 2015;94:32-6.
  7. Teggi R, Bellini C, Piccioni LO, Palonta F, Bussi M. Transmeatal low-level laser therapy for chronic tinnitus with cochlear dysfunction. Audiol Neurootol 2009;14:115-20.
    Pubmed CrossRef
  8. Huang YY, Sharma SK, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy - an update. Dose Response 2011;9:602-18.
    Pubmed KoreaMed CrossRef
  9. Okhovat A, Berjis N, Okhovat H, Malekpour A, Abtahi H. Low-level laser for treatment of tinnitus: a self-controlled clinical trial. J Res Med Sci 2011;16:33-8.
    Pubmed KoreaMed
  10. Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response 2009;7:358-83.
    Pubmed KoreaMed CrossRef
  11. Schaffer M, Bonel H, oka R Sr, Schaffer PM, Busch M, Reiser M, et al. Effects of 780 nm diode laser irradiation on blood microcirculation: preliminary findings on time-dependent T1-weighted contrast-enhanced magnetic resonance imaging (MRI). J Photochem Photobiol B 2000;54:55-60.
    Pubmed CrossRef
  12. Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients. J Clin Laser Med Surg 1996;14:163-7.
    Pubmed CrossRef
  13. van Breugel HH, Bär PR. Power density and exposure time of He-Ne laser irradiation are more important than total energy dose in photo-biomodulation of human fibroblasts in vitro. Lasers Surg Med 1992;12:528-37.
    Pubmed CrossRef
  14. Passarella S, Casamassima E, Molinari S, Pastore D, Quagliariello E, Catalano IM, et al. Increase of proton electrochemical potential and ATP synthesis in rat liver mitochondria irradiated in vitro by helium-neon laser. FEBS Lett 1984;175:95-9.
    Pubmed CrossRef
  15. Reddy GK, Stehno-Bittel L, Enwemeka CS. Laser photostimulation of collagen production in healing rabbit Achilles tendons. Lasers Surg Med 1998;22:281-7.
    Pubmed CrossRef
  16. Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR, Khanna A, Kornowski R, et al. Low-power helium: neon laser irradiation enhances production of vascular endothelial growth factor and promotes growth of endothelial cells in vitro. Lasers Surg Med 2001;28:355-64.
    Pubmed CrossRef
  17. Tauber S, Schorn K, Beyer W, Baumgartner R. Transmeatal cochlear laser (TCL) treatment of cochlear dysfunction: a feasibility study for chronic tinnitus. Lasers Med Sci 2003;18:154-61.
    Pubmed CrossRef
  18. Plath P, Olivier J. Results of combined low-power laser therapy and extracts of Ginkgo biloba in cases of sensorineural hearing loss and tinnitus. Adv Otorhinolaryngol 1995;49:101-4.
    Pubmed CrossRef
  19. Cuda D, De Caria A. Effectiveness of combined counseling and low-level laser stimulation in the treatment of disturbing chronic tinnitus. Int Tinnitus J 2008;14:175-80.
  20. Salahaldin AH, Abdulhadi K, Najjar N, Bener A. Low-level laser therapy in patients with complaints of tinnitus: a clinical study. ISRN Otolaryngol 2012;2012:132060.
    Pubmed KoreaMed CrossRef
  21. Choi JE, Lee MY, Chung PS, Jung JY. A preliminary study on the efficacy and safety of low level light therapy in the management of cochlear tinnitus: a single blind randomized clinical trial. Int Tinnitus J 2019;23:52-7.
    Pubmed CrossRef
  22. Xia N, Wu XY, Wang X, Mou ZX, Wang MQ, Gu X, et al. Pulsed 808-nm infrared laser stimulation of the auditory nerve in guinea pig cochlea. Lasers Med Sci 2014;29:343-9.
    Pubmed CrossRef
  23. Park YM, Na WS, Park IY, Suh MW, Rhee CK, Chung PS, et al. Trans-canal laser irradiation reduces tinnitus perception of salicylate treated rat. Neurosci Lett 2013;544:131-5.
    Pubmed CrossRef
  24. Tauber S, Baumgartner R, Schorn K, Beyer W. Lightdosimetric quantitative analysis of the human petrous bone: experimental study for laser irradiation of the cochlea. Lasers Surg Med 2001;28:18-26.
    Pubmed CrossRef
  25. Laakso L, Richardson C, Cramond T. Factors affecting Low Level Laser Therapy. Aust J Physiother 1993;39:95-9.
    Pubmed CrossRef
  26. Mirvakili A, Mehrparvar A, Mostaghaci M, Mollasadeghi A, Mirvakili M, Baradaranfar M, et al. Low level laser effect in treatment of patients with intractable tinnitus due to sensorineural hearing loss. J Lasers Med Sci 2014;5:71-4.
    Pubmed KoreaMed
  27. Ngao CF, Tan TS, Narayanan P, Raman R. The effectiveness of transmeatal low-power laser stimulation in treating tinnitus. Eur Arch Otorhinolaryngol 2014;271:975-80.
    Pubmed CrossRef
  28. Mollasadeghi A, Mirmohammadi SJ, Mehrparvar AH, Davari MH, Shokouh P, Mostaghaci M, et al. Efficacy of low-level laser therapy in the management of tinnitus due to noise-induced hearing loss: a double-blind randomized clinical trial. ScientificWorldJournal 2013;2013:596076.
    Pubmed KoreaMed CrossRef
  29. Nakashima T, Ueda H, Misawa H, Suzuki T, Tominaga M, Ito A, et al. Transmeatal low-power laser irradiation for tinnitus. Otol Neurotol 2002;23:296-300.
    Pubmed CrossRef
  30. Mirz F, Zachariae R, Andersen SE, Nielsen AG, Johansen LV, Bjerring P, et al. The low-power laser in the treatment of tinnitus. Clin Otolaryngol Allied Sci 1999;24:346-54.
    Pubmed CrossRef
  31. Chen CH, Huang CY, Chang CY, Cheng YF. Efficacy of low-level laser therapy for tinnitus: a systematic review with meta-analysis and trial sequential analysis. Brain Sci 2020;10:931.
    Pubmed KoreaMed CrossRef
  32. Montazeri K, Mahmoudian S, Razaghi Z, Farhadi M. Alterations in auditory electrophysiological responses associated with temporary suppression of tinnitus induced by low-level laser therapy: a before-after case series. J Lasers Med Sci 2017;8(Suppl 1):S38-45.
    Pubmed KoreaMed CrossRef
  33. Noreña AJ. An integrative model of tinnitus based on a central gain controlling neural sensitivity. Neurosci Biobehav Rev 2011;35:1089-109.
    Pubmed CrossRef
  34. Kadner A, Viirre E, Wester DC, Walsh SF, Hestenes J, Vankov A, et al. Lateral inhibition in the auditory cortex: an EEG index of tinnitus? Neuroreport 2002;13:443-6.
    Pubmed CrossRef

This Article

Cited By Articles
  • CrossRef (0)
  • Download (261)

Author ORCID Information


Social Network Service